Clinical Trial Update: Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 study of crizotinib in children and adolescents with inflammatory myofibroblastic tumor is underway, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Myofibroblastic Tumor

Drugs mentioned

• Crizotinib (crizotinib)

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Inflammatory Myofibroblastic Tumor | Phase 2, Phase 3 | Status: UNKNOWN